ustwo, the global digital product studio, today announced a year of significant global progress, marked by rapid expansion of its US operations and strong, sustained growth across its healthcare portfolio.
The performance reflects the studio’s strategic focus on high-impact digital products in regulated, mission-critical sectors, and the increasing demand for user-centred design in healthcare and enterprise environments.
Global commercial strength and multi-year resilience:
ustwo’s 2025 commercial performance reflects its position as a trusted partner for regulated and high-complexity digital programmes:
-
70%+ of major engagements this year have been multi-year partnerships.
-
The studio worked with over 40 organisations across three continents.
-
Over 40% of new briefs relate to AI-enabled experiences, system modernisation, or long-term digital transformation.
The New York, London, Malmö, Lisbon and Tokyo studios have increasingly collaborated on blended, cross-regional delivery teams – now a hallmark of ustwo’s global model – allowing the company to scale complex programmes while maintaining craft, speed and quality.
Key client wins in 2025 include L’Oreal, eBay, Blackrock, Google, BUPA and Centrica.
US growth surges as New York becomes a strategic hub:
2025 has been a defining year for ustwo’s US business. Booked revenue from the New York studio grew more than 400% year-on-year, driven by a surge in large-scale RFP activity, deeper partnerships with enterprise clients, and ustwo’s expanding role in complex, high-trust programmes across healthcare, finance, media and public services.
Ted Ismert, Executive Director of Client Services and Growth, joined earlier in 2025. Since joining the executive team earlier this year, Ismert has supported both commercial growth and organisational expansion, with the New York team now preparing for a further phase of growth and capability investment in early 2026.
“The momentum we’re seeing in the US is unlike anything in recent years,” said Ted Ismert, Executive Director of Client Services and Growth at ustwo. “Clients are coming to us because they need a partner who can deliver engagement, quality and user trust in environments where the stakes are high. Our strength in healthcare, behavioural design and AI-enabled experiences aligns directly with where the US market is heading.”
Healthcare emerges as one of ustwo’s fastest-growing verticals:
Healthcare and life sciences now represent a greater share of ustwo’s portfolio than ever before, with the studio delivering multiple new digital products and service enhancements for medtech companies, health platforms and patient-facing services in 2025.
Demand is being fuelled by a sector-wide shift toward more engaging, clinically safe and behaviour-changing digital experiences. With 50% of users deleting health apps after a single use, organisations are increasingly turning to ustwo for solutions that improve engagement and measurable outcomes.
“Our healthcare partners are asking for products that are not only compliant and secure, but genuinely valuable to the people who use them,” said Helen Fuchs, Executive Director of Design at ustwo. “Our work this year shows how human-centred design, when paired with rigorous technical execution, can lift long-term engagement and drive sustainable business impact.”
The studio has invested accordingly, expanding its health-focused output across the US, UK and Europe, and deepening its capability in behaviour-led UX, AI-augmented decision workflows and modernisation of legacy systems.
Positioned for 2026 and beyond:
With structural growth in both healthcare and US demand, ustwo plans to continue scaling its global footprint throughout 2026. Investments will focus on enterprise delivery capability, AI-enabled product strategy, and expanding our studios to meet rising client needs in transformation, safety-critical workflows and behaviour-changing digital products.
“2025 has shown the impact of staying focused on creating genuinely engaging products — work that resonates with people and drives meaningful change,” said Nicki Sprinz, CEO of ustwo. “Our distinctive framework shapes how we uncover opportunities, ideate, and bring products to life at scale. The growth we’re seeing, particularly in healthcare and the US, reflects the trust partners place in us and marks an exciting next chapter for ustwo.”
